Drawing for HALLAM BIOTECHNOLOGY

USPTO serial 76141243

HALLAM BIOTECHNOLOGY

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
FINNEGAN, TIMOTHY
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with HALLAM BIOTECHNOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Henry Y. Tang, Esq.

HENRY Y TANG ESQ BAKER BOTTS LLP30 ROCKEFELLER PLZNEW YORK, NY 10112-0002UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical and biological products for use in industry, science and research; biochemicals for use in industry, science and research; antibodies; monoclonal anti-bodies, polyclonal antibodies; purified recombinant proteins; purified natural proteins, purified enzymes; partially purified enzymes; research and industrial reagents; buffers; biochemical catalysts; biological preparationsACTIVE—
005Pharmaceutical preparations and substances; fungicides, herbicides, insecticides, pesticides, bactericides, disinfectants; dietetic preparations and substances; media for bacteriological cultures; bacteriological preparations for medical and veterinary use; diagnostic preparations for medical purposes; enzyme preparations; pharmaceutical ferments; medicines for human and veterinary purposesACTIVE—
009Apparatus and instruments for scientific and industrial use in the biotechnological and biomedical fieldACTIVE—
042Professional consultancy and research services; biological research; bacteriological research; research and development of new products; industrial and scientific research development and testing; laboratory research, testing and analysis; research and development services; analysis services; design services in the biotechnological and biomedical field; provision of laboratory services; provision of laboratory equipmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jan 5, 2002ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 7, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 12, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance